Utilizing Patient Electronic Medical Records to Transform Clinical Trials

Phase 3 clinical trials are resource-intensive and often fail to capture real-world patient experiences, but the practical advantages, challenges, and implementation requirements of integrating patient EMRs into trial infrastructure had not been comprehensively synthesized for a pharma audience.

Target RWE researchers presented a framework for integrating patient EMRs into Phase 3 clinical trials, covering efficiency advantages in recruitment and monitoring, data integrity and privacy challenges, and real-time monitoring capabilities.

Articulating the value and operational requirements of EMR integration in clinical trials positions Target RWE's registry infrastructure as a natural partner for sponsors seeking to modernize Phase 3 data collection.

EMR integration framework for Phase 3 clinical trial efficiency and patient-centricity, Registry-based EMR linkage infrastructure positioning for pharma partner clinical development programs